CURRENT TREATMENT OF RHEUMATOID ARTHRITIS: RECOMMENDATIONS AND ACTUAL PRACTICE


N.V. Chichasova, G.R. Imametdinova

Department of Rheumatology IPGE SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH, Moscow
To date, the treatment of rheumatoid arthritis (RA) has some success. The emergence of new diagnostic criteria 2010 for RA, implementation of the principles of controlled treatment in practice – strategy of treatment of RA to achieve the goal, the emergence of new forms of previously used disease modifying anti-rheumatic drugs (DMARDs) and new generation preparations (genetically engineered biological agents and the targeted synthetic DMARDs) - tofacitinib, allows to approach to personalized treatment of RA and the prevention of adverse outcomes. The widespread introduction of the subcutaneous form of methotrexate into clinical practice, a highly effective drug in relation to the activity and progression in early RA, well tolerated for a long time, allows to achieve the goal for most patients after 6-12 months of therapy using the principles of controlled treatment.

About the Autors


Chichasova N.V. – MD, Prof. at the Department of Rheumatology, IPGE SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH; e-mail: kafedrarheum@yandex.ru
Imametdinova G.R. - Associate Professor at the Department of Rheumatology, IPGE SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH


Similar Articles


Бионика Медиа